Svelte Medical Systems

Delivers novel products in the coronary stent market to curb key clinical issues by improving stent deliverability.

Launch date

2007

Employees

Market cap

Enterprise valuation

New Providence Iowa (HQ)

Date	Investors	Amount	Round
-	Savitr Capital	N/A	-
May 2009	New Science Ventures	$6.3m	Early VC
Nov 2009	Apjohn ventures	$6.0m	Debt
Nov 2010	Apjohn ventures	$9.7m	Debt
Dec 2011	New Science Ventures	$18.8m	Late VC
Jun 2012	Apjohn ventures	$5.0m	Debt
Apr 2013	Apjohn ventures	$1.8m	Debt
Mar 2014	New Science Ventures	$5.0m	Early VC
Feb 2016	New Science Ventures	$44.4m	Growth Equity VC
Jul 2016	Apjohn ventures	$4.0m	Debt
Oct 2018	New Science Ventures CNF Investments, LLC	$22.0m	Late VC
Total Funding		€87.7m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Svelte Medical Systems